The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study: Open Forum Infect Dis. 2024 Dec 31;12(1):ofae756. doi: 10.1093/ofid/ofae756

By afschroeder • September 23, 2025

Rubin SA. The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study: Open Forum Infect Dis. 2024 Dec 31;12(1):ofae756. doi: 10.1093/ofid/ofae756. Open Forum Infect Dis. 2025 Aug 21;12(9):ofaf480. doi: 10.1093/ofid/ofaf480. PMID: 40980592; PMCID: PMC12449218.

Tags: Cardiology/Epi, Publications, Veterans Administration

Macroscopic and microscopic observations of a helix-fixation type leadless pacemaker 1 month after implantation

Miyazaki Y, Rimmer M, Bender AB, Hanna P, Hayase JH, Do DH, Xu S, Ajijola OA, Fishbein MC, Shivkumar K, Mori S. Macroscopic and microscopic[...]

Cardiotoxicity of T cell immunotherapies

Raddatz MA, Stein-Merlob AF, Mahmood SS, Ganatra S, Addison D, Lin TL, Larson SM, Yang EH. Cardiotoxicity of T cell immunotherapies. Nat Rev Cardiol. 2026[...]

Risk of kidney failure and death associated with target-dose (vs. below-target-dose) RAS inhibitors in HFrEF, HFmrEF and HFpEF: Spline-based reassessment of subgroup findings

Raman VK, Vargas JD, Moore HJ, Wu WC, Patel SS, Zhang S, Morgan CJ, Lam PH, Heidenreich PA, Lu F, Ahmed AA, Fonarow GC, Ahmed[...]